Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle

European Journal of Pharmacology

Volumn 516, Issue 3, 2005, Pages 276-281

  Behm, David J ^a   Ao, Zhaohui ^a   Camarda, Valeria ^a,b   Aiyar, Nambi V ^a   Johns, Douglas G ^a   Douglas, Stephen A ^a  

^a GLAXOSMITHKLINE   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

BIM 23127; Bronchus; GPR14; GSK248451; SB 710411; Trachea; Urotensin II; UT receptor

Indexed keywords

BIM 23127; GSK 248451; MESSENGER RNA; PHENYLALANINE DERIVATIVE; POTASSIUM CHLORIDE; RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; RECOMBINANT UROTENSIN; SB 710411; UNCLASSIFIED DRUG; UROTENSIN; UROTENSIN II;

ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; BRONCHOSPASM; BRONCHUS; CAT; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; LUNG PARENCHYMA; MUSCLE CONTRACTION; NONHUMAN; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE TONE; STATISTICAL SIGNIFICANCE; TRACHEA;

ANIMALS; BINDING, COMPETITIVE; BLOTTING, NORTHERN; BRONCHI; CATS; CELL LINE; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; HUMANS; IODINE RADIOISOTOPES; LUNG; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PEPTIDES, CYCLIC; POTASSIUM CHLORIDE; RADIOLIGAND ASSAY; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRACHEA; UROTENSINS;

EID: 21544434938     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.04.043     Document Type: Article

References (23)

1. R.S. Ames, H.M. Sarau, J.K. Chambers, R.N. Willette, N.V. Aiyar, A.M. Romanic, C.S. Louden, J.J. Foley, C.F. Sauermelch, R.W. Coatney, Z. Ao, J. Disa, S.D. Holmes, J.M. Stadel, J.D. Martin, W.S. Liu, G.I. Glover, S. Wilson, D.E. McNulty, C.E. Ellis, N.A. Elshourbagy, U. Shabon, J.J. Trill, D.W.P. Hay, E.H. Ohlstein, D.J. Bergsma, and S.A. Douglas Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 Nature 401 1999 282 286
2. D.J. Behm, C.L. Herold, E.H. Ohlstein, S.D. Knight, D. Dhanak, and S.A. Douglas Pharmacological characterization of SB-710411 (Cpa-c[d-Cys-Pal-d-Trp- Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist Br. J. Pharmacol. 137 2002 449 458
3. D.J. Behm, D.G. Johns, V. Camarda, N.V. Aiyar, and S.A. Douglas Differential antagonistic properties of novel peptidic UT receptor antagonists in feline isolated arteries: evidence for the existence of UT receptor subtypes? Pharmacologist 45 2003 138 139
4. D.J. Behm, C.P. Doe, D.G. Johns, K. Maniscalco, G.P. Stankus, A. Wibberley, R.N. Willette, and S.A. Douglas Urotensin-II: a novel systemic hypertensive factor in the cat Naunyn-Schmiedeberg's Arch. Pharmacol. 369 2004 274 280
5. D.J. Behm, C.L. Herold, V. Camarda, N.V. Aiyar, and S.A. Douglas Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors Eur. J. Pharmacol. 492 2004 113 116
6. Y.H. Chen, M.W. Zhao, W.Z. Yao, Y.Z. Pang, and C.S. Tang The signal transduction pathway in the proliferation of airway smooth muscle cells induced by urotensin II Chin. Med. J. 117 2004 37 41
7. D.H. Coy, W.J. Rossowski, B.L. Cheng, S.J. Hocart, and J.E. Taylor Novel urotensin-II (UII) antagonists point to multiple receptor involvement in UII bioactivity Regul. Pept. 94 2000 48
8. D.H. Coy, W.J. Rossowski, B.L. Cheng, and J.E. Taylor Highly potent heptapeptide antagonists of the vasoactive peptide urotensin II Abstracts of papers, 225th ACS National meeting New Orleans, LA, United States, March 23-27 2003 American Chemical Society Washington, D.C.
9. L. De Garavilla, J. Qi, R. Santulli, P. Andrade-Gordon, and W.M. Abraham Inhalation of urotensin-II increases airway resistance in sheep Am. J. Respir. Crit. Care Med. 163 2001 A924
10. S.A. Douglas, and E.H. Ohlstein Urotensin receptors D. Girdlestone The IUPHAR Compendium of Receptor Characterization and Classification 2000 IUPHAR Media London 365 372
11. S.A. Douglas, G.R. Beck, J.D. Elliott, and E.H. Ohlstein Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein Br. J. Pharmacol. 114 1995 1529 1540
12. S.A. Douglas, A.C. Sulpizio, V. Piercy, H.M. Sarau, R.S. Ames, N.V. Aiyar, E.H. Ohlstein, and R.N. Willette Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey Br. J. Pharmacol. 131 2000 1262 1274
13. S.A. Douglas, Z. Ao, D.G. Johns, K. Maniscalco, R.N. Willette, L. Sarov-Blat, J.P. Cogswell, S. Seepersaud, P. Murdock, K.M. Steplewski, and L. Patel Quantitative analysis of orphan G protein-coupled receptor mRNAs by TaqMan real-time PCR A.P. Davenport Receptor Binding Techniques 2005 Humana Press Totowa, NJ 27 49
14. N.A. Elshourbagy, S.A. Douglas, U. Shabon, S. Harrison, G. Duddy, J.L. Sechler, Z. Ao, B.E. Maleeff, D. Naselsky, J. Disa, and N.V. Aiyar Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey Br. J. Pharmacol. 136 2002 9 22
15. D.W. Hay, M.A. Luttmann, and S.A. Douglas Human urotensin-II is a potent spasmogen of primate airway smooth muscle Br. J. Pharmacol. 131 2000 10 12
16. C.L. Herold, D.J. Behm, P.T. Buckley, J.J. Foley, W.E. Wixted, H.M. Sarau, and S.A. Douglas The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors Br. J. Pharmacol. 139 2003 203 207
17. D.H. Jenkinson, E.A. Barnard, D. Hoyer, P.P.A. Humphrey, P. Leff, and N.P. Shankley Terms and symbols in quantitative pharmacology D. Girdlestone The IUPHAR Compendium of Receptor Characterization and Classification 1998 IUPHAR Media London 6 20
18. M.R. MacLean, D. Alexander, A. Stirrat, M. Gallagher, S.A. Douglas, E.H. Ohlstein, I. Morecroft, and K. Polland Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat Br. J. Pharmacol. 130 2000 201 204
19. J.J. Maguire, R.E. Kuc, and A.P. Davenport Orphan-receptor ligand human urotensin-II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 Br. J. Pharmacol. 131 2000 441 446
20. H.P. Nothacker, Z. Wang, A.M. McNeill, Y. Saito, S. Merten, B. O'Dowd, S.P. Duckles, and O. Civelli Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction Nat. Cell Biol. 1 1999 383 385
21. J. Qi, J. Du, X. Tang, J. Li, B. Wei, and C. Tang The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting Heart Vessels 19 2004 81 88
22. F.D. Russell, D. Meyers, A.J. Galbraith, N. Bett, I. Toth, P. Kearns, and P. Molenaar Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure Am. J. Physiol, Heart Circ. Physiol. 285 2003 H1576 H1581
23. Y. Zhang, J. Li, J. Cao, J. Chen, J. Yang, Z. Zhang, J. Du, and C. Tang Effect of chronic hypoxia on contents of urotensin II and its functional receptors in rat myocardium Heart Vessels 16 2002 64 68